ADAR1 Capital Management »

Tmt Acquisition Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Tmt Acquisition Corp (TMTC) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Tmt Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Tmt Acquisition Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tmt Acquisition Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $535k 50k 10.69
2023-12-31 $530k 50k 10.60

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Tmt Acquisition Corp

Karpus Investment Management
Mizuho Securities USA
Westchester Capital Management
Wolverine Asset Management
Berkley W R
Vivaldi Asset Management
Quarry
Rivernorth Capital Management
MMCAP International Inc. SPC
Polar Securities
Atw Spac Management
Fir Tree
D. E. Shaw & Co
Gabelli Funds
Glazer Capital

View all funds holding Tmt Acquisition Corp